FDA Inspection
Novast Laboratories Ltd.FDA Inspection 1215392 - Novast Laboratories Ltd. - July 14, 2023
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Novast Laboratories Ltd., with an inspection on July 14, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 5337cb22-16e5-4822-a935-ae4d1cb2c461
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1215392
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Novast Laboratories Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 13, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 15, 2016 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 5, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 29, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |